IGM Biosciences Inc. (IGMS) Misses Q3 EPS by 21c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q3 EPS of ($1.01), $0.21 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $520 thousand versus the consensus estimate of $230.56 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices